Project Number GC-2012786 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2016 View Full Project Details for Phase 1 First-in-Human Multiple Ascending Dose Study of the Putative Cognitive Enhancer and M1 Positive Allosteric Modulator VU0467319 Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) d. Neurotransmitter Receptors Researcher and Organization Principal Investigator Newhouse, Paul Principal Investigator First Name Paul Principal Investigator Last Name Newhouse Awardee Organization VANDERBILT UNIVERSITY MEDICAL CENTER Awardee State Tennessee Contact PI Country United States Project Detail Funding Opportunity Announcement PACT Program FY Overall Cost $1,271,174 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
